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RESEARCH ARTICLE
Mosaic expression of Atrx in the mouse central nervous system
causes memory deficits
Renee J. Tamming1,2, Jennifer R. Siu1,3, Yan Jiang1,2, Marco A. M. Prado3,4, Frank Beier1,3 and
Nathalie G. Bérubé1,2,*
ABSTRACT
The rapid modulation of chromatin organization is thought to play a
crucial role in cognitive processes such as memory consolidation.
This is supported in part by the dysregulation of many chromatin-
remodelling proteins in neurodevelopmental and psychiatric
disorders. A key example is ATRX, an X-linked gene commonly
mutated in individuals with syndromic and nonsyndromic intellectual
disability. The consequences of Atrx inactivation for learning and
memory have been difficult to evaluate because of the early lethality
of hemizygous-null animals. In this study, we evaluated the outcome
of brain-specific Atrx deletion in heterozygous female mice. These
mice exhibit a mosaic pattern of ATRX protein expression in the
central nervous system attributable to the location of the gene on the
X chromosome. Although the hemizygous male mice die soon after
birth, heterozygous females survive to adulthood. Body growth is
stunted in these animals, and they have low circulating concentrations
of insulin growth factor 1. In addition, they are impaired in spatial,
contextual fear and novel object recognition memory. Our findings
demonstrate that mosaic loss of ATRX expression in the central
nervous system leads to endocrine defects and decreased body size
and has a negative impact on learning and memory.
KEY WORDS: ATRX, Central nervous system, Mouse models,
Neurobehaviour
INTRODUCTION
Alpha thalassemia mental retardation, X-linked, or ATR-X
syndrome, is an intellectual disability (ID) disorder that arises
from mutations in the ATRX gene (OMIM 301040). This rare
syndrome is characterized by severe developmental delay,
hypotonia, mild α-thalassemia and moderate-to-severe ID
(Gibbons et al., 1995). A recent study screened a cohort of nearly
1000 individuals with ID using targeted next-generation sequencing
and identified ATRX variants as one of the most common causes of
ID, reinforcing its importance in cognition (Grozeva et al., 2015).
The ATRX protein is a SWI/SNF-type chromatin remodeller. The
N-terminal region of the protein contains a histone reader domain
that mediates interaction of the protein with histone H3
trimethylated at lysine 9 (H3K9me3) and unmethylated at lysine 4
(H3K4me0) (Dhayalan et al., 2011). A SWI/SNF2-type helicase
domain is located in the C-terminal half of the protein and confers
ATP-dependent chromatin remodelling activity (Aapola et al.,
2000; Gibbons et al., 1997; Picketts et al., 1996). Several proteins
have been shown to interact with ATRX, including MeCP2, HP1α,
EZH2 and DAXX (Bérubé et al., 2000; Cardoso et al., 1998; Nan
et al., 2007; Xue et al., 2003). DAXX is a histone chaperone for
histone variant H3.3. In association with ATRX, DAXX deposits
H3.3-containing nucleosomes at telomeres and pericentromeric
heterochromatin (Drane et al., 2010; Lewis et al., 2010).
Several studies have previously implicated ATRX in the
regulation of gene expression through a variety of mechanisms.
Chromatin immunoprecipitation (ChIP) sequencing for ATRX in
human erythroblasts showed that the protein tends to bind GC-rich
regions with high tendency to form G-quadruplexes. For example,
ATRXwas found to bind tandem repeats within the human α-globin
gene cluster, and it was suggested that reduced expression of α-
globin might be caused by replication-dependent mechanisms that
would affect the expression of nearby genes (Law et al., 2010). The
induction of replication stress was in fact detected in vivo upon
inactivation of Atrx in either muscle or brain (Leung et al., 2013;
Watson et al., 2013). More recently, our group demonstrated that
loss of ATRX corresponds to decreased H3.3 incorporation and
increased PolII occupancy in GC-rich gene bodies, including
Neuroligin 4, an autism susceptibility gene (Levy et al., 2015).
Although the mechanisms by which ATRX modulates chromatin
and genes is starting to be resolved, its function in neurons and
cognitive processes is still obscure. To address this question, we
generated mice with conditional inactivation of Atrx in the central
nervous system (CNS) starting at early stages of neurogenesis.
Although hemizygous male progeny died shortly after birth,
heterozygous female mice (henceforth called Atrx-cHet), which
exhibit mosaic expression of ATRX caused by random X-
inactivation, survived to adulthood, allowing the investigation of
neurobehavioural outcomes upon inactivation of Atrx in the brain.
RESULTS
Survival to adulthood depends on the extent of Atrx deletion
in the CNS
Conditional inactivation of Atrx is required to elucidate its functions
in specific tissues, because general inactivation of the gene is
embryonic lethal (Garrick et al., 2006).We thus generated micewith
Cre recombinase-mediated deletion of Atrx-floxed alleles in the
CNS using the Nestin-Cre driver line of mice. Hemizygous male
mice (Atrx-cKO) died by postnatal day (P)1 (Fig. 1A). Owing to
random X-inactivation in females, Atrx is expressed from only oneReceived 13 August 2016; Accepted 7 December 2016
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of the alleles in any specific cell, resulting in a mosaic pattern of
expression in the brain of Atrx-cHet mice (e.g. if the floxed allele is
the active allele, these cells are functionally null for Atrx; however,
if the floxed allele is the silent one, cells are functionally wild type
for Atrx). This was validated by RT-qPCRwith Atrx primers in exon
17 and the excised exon 18, showing ∼50% decreased Atrx
expression in the cortex and hippocampus of Atrx-cHet mice
compared with littermate controls (Fig. 1B). Moreover, a mosaic
pattern of ATRX protein expression was observed by
immunofluorescence staining of the hippocampus and medial
prefrontal cortex (Fig. 1C,D). This was quantified in the medial
prefrontal cortex in three pairs of control and cKO animals (Fig. 1E).
Haematoxylin and Eosin staining of control and Atrx-cHet brain
sections did not reveal major histological alterations in the CA1,
CA3 and mPFC regions (Fig. 1F). These results demonstrated that
inactivation of Atrx throughout the CNS was perinatal lethal but that
Atrx deletion in approximately half of cells allowed survival of the
female heterozygous mice to adulthood.
Mosaic inactivation of Atrx in the CNS impedes normal body
growth
Atrx-cHet mice were weighed weekly for the first 24 postnatal
weeks. The data showed that the Atrx-cHet mice weighed
significantly less than control mice over this time period
(F=17.87, P=0.0003; Fig. 2A,B). Alcian Blue and Alizarin Red
skeletal staining of P17 mice reveal that the Atrx-cHet skeletons
were smaller than those of the control mice (Fig. 2C). Tibia, femur
and humerus bones were also measured and found to be
significantly shorter in the Atrx-cHet mice compared with
littermate controls (Fig. 2D).
We previously reported that deletion of Atrx in the developing
mouse forebrain and anterior pituitary leads to low circulating
Fig. 1. MosaicpatternofATRXexpression in thebrainofAtrx-cHetmice. (A)Graphdepicting thesurvival of controlmalemice (n=20), knockoutmalemice (n=6),
control female mice (n=14) and heterozygote female mice (n=17) as the percentage survival at each time point. (B) RT-qPCR of Atrx (normalized to Gapdh
expression) in the hippocampus and cortex of Atrx-cHet mice and littermate-matched controls (mean±s.e.m. of n=4 pairs, Student’s two-tailed unpaired t-test).
*P<0.05. (C) Immunofluorescencestaining ofATRX (red)andDAPI (blue) in thehippocampusof control andAtrx-cHetmice.Scalebar: 100 μm.CA1, cornusammoni
1; CA3, cornus ammoni 3; DG, dentate gyrus. (D) Immunofluorescence staining of ATRX (red) and DAPI (blue) in themedial prefrontal cortex (mPFC) of control and
Atrx-cHet mice. Scale bar: 200 μm. (E) The percentage of ATRX-positive cells in the mPFC of control and Atrx-cHet mice (mean of three pairs±s.e.m., Student’s
two-tailed unpaired t-test). *P<0.05. (F) Haematoxylin and Eosin staining in the CA1, CA3 and mPFC of control and Atrx-cHet mice. Scale bar: 200 μm.
120
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 119-126 doi:10.1242/dmm.027482
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
concentrations of IGF-1 and thyroxine (T4) (Watson et al., 2013).
Some evidence suggests that T4 regulates the prepubertal
concentrations of insulin growth factor 1 (IGF-1), whereas after
puberty this regulation is largely mediated by growth hormone (GH)
(Xing et al., 2012). Given that the Atrx-cHet mice were smaller than
control mice, we examined the concentrations of T4, IGF-1 and GH
in the blood by enzyme-linked immunosorbent assasy (ELISAs).
We observed no significant difference in T4 and GH concentrations
between P17 Atrx-cHet mice and control littermates. However, there
was a large (80%) and significant decrease in IGF-1 concentrations
(Fig. 2E). Thus, the reduced body size of the Atrx-cHet mice was
correlated with low circulating IGF-1 concentrations.
Fig. 2. Atrx-cHet mice have reduced body
weight and low circulating IGF-1. (A) Atrx-cHet
female mice are smaller than littermate-matched
controls at P17. (B) Growth curve of mice from 3 to
24 weeks of age (n=13; *P<0.05). Data are
represented as means±s.e.m., two-way repeated-
measures ANOVAwith Benjamini–Hochburg post-
hoc test. (C) Skeletal stains of P21 control and
Atrx-cHet mice showing cartilage (blue) and bone
(red). (D) The lengths of long bones of Atrx-cHet
mice (n=21) are decreased compared with control
mice (n=19). (E) Circulating concentrations of T4,
GH and IGF-1 in Atrx-cHet and control mice (n=3)
at P17. Data are represented as means±s.e.m.,
Student’s two-tailed, unpaired t-test. *P<0.05.
Fig. 3.Atrx-cHet mice exhibit hindlimb clasping
but normal activity and anxiety levels.
(A) Hindlimb clasping was evaluated in control
(n=13) and Atrx-cHet (n=12) female mice and data
plotted as the proportion of mice with hindlimb
clasping from 3 to 25 weeks of age. (B,C) The
open-field test showed no difference in distance
travelled (B) and time spent in the centre
(C) between control (n=11) and Atrx-cHet female
mice (n=14). (D) Elevated plus maze test shows no
difference in time spent in the open and closed
arms in control (n=11) andAtrx-cHet (n=13) female
mice. The data are represented as means±s.e.m.
and a two-way ANOVA test was performed.
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Hindlimb-clasping phenotype in Atrx-cHet mice
The Atrx-cHet mice displayed increased hindlimb clasping
compared with control mice, with >90% exhibiting limb clasping
by 3 months of age (F=20.78, P<0.0001; Fig. 3A). In the open-field
test, the distance travelled was not significantly different between
control and Atrx-cHet mice, indicating that activity and locomotion
were normal (F=0.20, P=0.66; Fig. 3B). Anxiety levels were also
normal, based on the time spent in the centre of the open-field
apparatus (F=0.84, P=0.44; Fig. 3C). Likewise, their performance
in the elevated plus maze revealed no significant difference in the
amount of time that control and Atrx-cHet mice spent in the open
versus closed arms (F=0.68, P=0.41; Fig. 3C,D). We concluded that
the Atrx-cHet mice were not hyper- or hypo-active and did not
exhibit excessive anxiety, but the increased level of hindlimb-
clasping behaviour was suggestive of neurological defects.
Atrx-cHet mice have normal working memory but deficits in
object recognition memory
Given that ATRX mutations are linked to ID, we next evaluated
memory in Atrx-cHet mice using various established paradigms.We
first tested short-term working memory in the Y-maze task (de
Castro et al., 2009). No difference was detected between control and
Atrx-cHet mice in the percentage alternation or in the number of
entries into the arms, suggesting that working memory was normal
in Atrx-cHet mice (t=0.05, P=0.96; Fig. 4A). We then tested the
Atrx-cHet mice in the spontaneous novel object recognition task that
mainly involves the prefrontal cortex and hippocampus (Ennaceur
and Delacour, 1988). In rodents, the natural tendency to seek out
and explore novelty leads to a preference for the novel over the
familiar object, indicating recognition memory of the familiar object
(Bevins and Besheer, 2006). During the habituation period, both
control and Atrx-cHet mice spent ∼50% of the allotted time with
each individual object (Fig. 4B). In the course of the short-term
memory test (1.5 h), control mice spent ∼70% of their time with the
novel object, whereas Atrx-cHet mice still spent ∼50% of their time
with each object, suggesting an inability to remember the familiar
object (Fig. 4B). Similar results were obtained in the long-term
memory test (24 h). The total amount of time spent interacting with
the objects was unchanged between control and Atrx-cHet mice
during all three tests, ruling out visual or tactile impairment.
Atrx-cHetmice display deficits in contextual fear and spatial
memory
To evaluate contextual fear memory, mice were placed in a box with
distinctive black and white patterns on the sides for 3 min and
shocked after 2.5 min. Twenty-four hours later, they were placed
back into the same box with the same contextual cues, and the time
spent freezing was measured at 30 s intervals. The data showed that
the Atrx-cHet mice spent less time freezing than control mice
(F=28.57, P<0.0001), and the total percentage of immobility time
was significantly lower for Atrx-cHet mice, indicating impaired fear
memory in these mice (t=5.35, P<0.0001; Fig. 4C).
The Morris water maze was next used to evaluate hippocampus-
dependent spatial memory (Morris, 1984). During the 4 days of
training, the Atrx-cHet mice took significantly more time finding the
target platform while swimming a longer distance compared with
control mice (latency F=31.44, P<0.0001; distance F=12.29,
P<0.01; Fig. 5A). The Atrx-cHet mice also swam more slowly
than control mice (F=15.40, P<0.001; Fig. 5A). During testing on
the fifth day, the platform was removed and the time spent in each
quadrant recorded as a measure of spatial memory. Whereas control
mice spent significantly more time in the target quadrant than the
Fig. 4. Impaired novel object recognition and
contextual fear memory in Atrx-cHet mice.
(A) Percentage alternation and number of arm
entries in the Y-maze test by control (n=14) and
Atrx-cHet (n=15) female mice. (B) Control (n=14)
and Atrx-cHet (n=14) mice displayed similar
preference for identical objects in the training
session of the novel object recognition task. The
Atrx-cHet mice failed to display a preference for the
novel object 1.5 and 24 h later (*P<0.05).
(C)Atrx-cHet (n=14) mice spent less time immobile
than control mice (n=14) in the fear-conditioning
paradigm. The total percentage of time spent
immobile is shown on the right (*P<0.0001).
Statistical analyses made use of Student’s two-
tailed, unpaired t-test or two-way ANOVA; data are
represented as means±s.e.m. and *P<0.05.
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left or opposite quadrant (F=4.70, P<0.01), Atrx-cHet mice showed
no preference for the target quadrant (F=0.75, P=0.53; Fig. 5B).
The results suggested that spatial learning and memory might be
impaired in the Atrx-cHet mice. The cued Morris water maze was
used to determine whether motivational or sensorimotor defects
contributed to the phenotype seen in the noncued version of the test.
Whereas the control mice quickly learned to correlate the cue with
the platform, the Atrx-cHet mice were unable to do so (F=14.09,
P<0.01; Fig. 5C). We noticed that the mice failed to show normal
signs of aversion to water during this task, with a preference to be
swimming rather than to climb on the platform during training, even
jumping back into the water after being placed on the platform.
Atrx-cHet mice have normal motor endurance and motor
memory
Given that the Atrx-cHet mice swam more slowly than control
animals in the Morris water-maze task, we considered that perhaps
the test was confounded by deficits in motor skills. To clarify this
issue, we examined endurance and motor skills further in the mutant
mice. We found that motor function and balance measured in the
Rotarod task were not significantly different in Atrx-cHet mice
during any of the trials (F=3.02, P=0.09; Fig. 6A). Atrx-cHet mice
also performed similarly to control animals in the treadmill task
(t=0.34, P=0.73; Fig. 6B). By contrast, Atrx-cHet mice exhibited
decreased forelimb grip strength, normalized to body weight
(t=2.80, P<0.05; Fig. 6C).
DISCUSSION
This study demonstrates that deletion of Atrx in the CNS leads to
endocrine defects and behavioural abnormalities. Specifically, we
see impairments in spatial learning and memory in the Morris water
maze, in contextual fear conditioning and in novel object
recognition.
We previously reported that mice lacking ATRX expression in
the embryonic mouse forebrain have an average lifespan of 22 days
(Watson et al., 2013). It is thus not surprising that inactivation of
Atrx using the Nestin-Cre driver (which mediates deletion in the
majority of CNS cells) is neonatal lethal. By contrast, the Atrx-cHet
female mice survived to adulthood, probably because roughly half
of all Nestin-expressing cells and their progeny are spared. Mosaic
loss of ATRX in Atrx-cHet female mice still negatively affects
development, as the mice are smaller compared with littermate
controls, and the length of long bones is decreased. As the
Nestin-Cre driver does not promote Cre expression in bone
progenitors (Wiese et al., 2004), this phenotype might result from
the low concentration of circulating IGF-1 in these mice. The reason
for low IGF-1 is difficult to pinpoint in our mice. It has been shown
that mice expressing Cre under the control of the Nestin promoter
are smaller as a result of a decrease in mouse GH (Declercq et al.,
2015). However, in our hands, GH concentrations are normal in the
Atrx-cHet mice. Given the normal concentrations of both T4 and
GH, there could be unanticipated expression of Cre in the liver that
affects IGF-1 production. Examining the potential off-target
expression of Cre will be required to elucidate the mechanism of
IGF-1 downregulation in these mice.
Fig. 5. Atrx-cHet mice perform poorly in the
Morris water-maze paradigm. (A) Atrx-cHet mice
(n=13) spent more time finding the platform
compared with control mice (n=11) over the four
consecutive days of training (*P<0.05). They swam
longer distances but at a lower speed compared
with control mice (*P<0.05). (B) Control mice spent
more time swimming in the target quadrant (T)
compared with the left (L) and opposite (O)
quadrants (*P<0.05) on the day 5 probe test,
whereas Atrx-cHet mice spent ∼25% of their time in
each of the quadrants. (C) In the cued version of the
Morris water maze, Atrx-cHet mice (n=11) were
unable to learn the location of the visible platform,
whereas the control mice could effectively learn this
task (n=11). Data are represented as means±s.e.m.
and a two-way ANOVA test was done. *P<0.05.
Fig. 6. Normal motormemory and endurance but decreased grip strength
in Atrx-cHet mice. (A) Atrx-cHet (n=18) and control (n=16) female mice
performed normally in the Rotarod test. (B)Atrx-cHet (n=15) and control (n=15)
mice exhibited similar performance in the treadmill test. (C) Atrx-cHet mice
(n=13) exhibited a decreased grip strength compared with control mice (n=11),
normalized to body mass. Statistical analyses made use of two-way ANOVA or
Student’s two-tailed, unpaired t-test; data are represented as means±s.e.m.
*P<0.05.
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The Atrx-cHet mice displayed a variety of behavioural
abnormalities. We initially noticed that the mice displayed
excessive hindlimb clasping, which could indicate neurological
impairment (Guyet al., 2001). This prompted us to perform additional
tests to assess neurobehaviour of the mice.We observed no change in
general activity or anxiety using the open-field test and elevated plus
maze, respectively, and no change in workingmemory in the Y-maze
task. The Atrx-cHet mice exhibited increased latency to reach the
platform in theMorris water-maze task, which might indicate a defect
in spatial memory. However, the findings are difficult to interpret
becauseAtrx-cHetmice swam at a lower speed,which could indicate a
problem with their ability to swim rather than with memory. It was
previously reported that mice lacking MeCP2 protein, an established
interactor with ATRX in the brain, exhibit navigational difficulties in
theMorris watermaze (Stearns et al., 2007). Significant differences in
swimming ability made it difficult to conclude whether the increased
latency to the platform was attributable to motor or cognitive deficits,
similar to our findings with the Atrx-cHet mice. Although we did not
observe defective motor skills in the Rotarod or treadmill tests or
decreased activity in the open-field test,we noticed that themice failed
to show normal signs of aversion to water during this task and
preferred to be swimming rather than to climb on the platform during
training, even jumping back into the water after being placed on the
platform. We attempted to test the mice in the Barnes maze, another
spatial learning and memory test, but the heterozygote mice tended to
jump off the edge of the maze. Based on these observations, it will be
important in the future to perform additional tests that gauge the level
of motivation in these mice.
Despite these issues, which might require further experimentation
for a full understanding, we obtained supporting evidence that
memory is affected in the Atrx-cHet mice in the contextual fear and
the novel object recognition tasks. Additional support comes from a
previous study done in a mouse model of Chudley–Lowry syndrome
associated with reduced expression of ATRX (Nogami et al., 2011).
The authors of that study reported an impairment in contextual fear
memory and suggested that ATRXmight play a role in regulation of
adult-born neurons. Our results show defects not only in contextual
fear memory, but also in novel object recognition and, potentially,
theMorris water-maze task. This might indicate a role for ATRX not
only in adult-born neurons, but perhaps also in the amygdala,
hippocampus and the rest of the medial temporal lobe, structures
which are vital for the tasks impaired in the Atrx-cHet mice (Phillips
and LeDoux, 1992; Logue et al., 1997; Wan et al., 1999).
The DAXX protein is a well-established interactor with ATRX.
Although the behaviour of DAXX knockout mice has not yet been
investigated, a study previously demonstrated that DAXX binds
with ATRX to the promoters of several immediate-early genes upon
activation of cortical neuronal cultures (Michod et al., 2012).
DAXXwas also shown to be crucial for the incorporation of histone
H3.3 at these gene promoters, supporting a potential role for DAXX
and ATRX the initial steps of memory consolidation. EZH2, a
member of the PRC2 complex that mediates H3K27 trimethylation,
is another putative binding partner of ATRX (Cardoso et al., 1998;
Margueron et al., 2009). Inducible deletion of the Ezh2 gene in
neural progenitor cells in the adult brain caused impaired spatial
learning and memory and contextual fear memory, suggesting that
EZH2 (potentially with ATRX) provides important cues in adult
neural progenitor cells (Zhang et al., 2014).
We emphasize that these mice do not model the ATR-X
syndrome, where only males are affected and females exhibit
100% skewing of X-chromosome inactivation and are therefore
largely unaffected. Rather, the Atrx-cHet mice are a useful tool to
probe ATRX function in the CNS. Overall, our study presents
compelling evidence that ATRX is required in the mouse CNS for
normal cognitive processes and sets the stage for additional
investigations delving into the mechanisms by which it regulates
chromatin structure and gene expression in neurons in the context of
learning and memory.
MATERIALS AND METHODS
Animal care and husbandry
Mice were exposed to a 12 h:12 h light–dark cycle and with water and chow
ad libitum. The AtrxloxPmice have been described previously (Bérubé et al.,
2005). AtrxloxP mice (129svj) were mated with mice expressing Cre
recombinase under the control of the Nestin gene promoter (Bl6) (Tronche
et al., 1999). The progeny include hemizygous male mice that produce no
full-length ATRX protein in the CNS (Atrxf/y Cre+) and heterozygous
female mice with approximately half the cells lacking ATRX protein as a
result of the random pattern of X-inactivation (Atrxf/+ Cre+). Male and
female littermate floxed mice lacking the Cre allele were used as controls.
Genotyping of tail biopsies for the presence of the floxed andCre alleles was
performed as described previously (Bérubé et al., 2005; Seah et al., 2008).
All procedures involving animals were conducted in accordance with the
regulations of the Animals for Research Act of the province of Ontario and
approved by the University of Western Ontario Animal Care and Use
Committee (2008-041). Behavioural assessments started with less-
demanding tasks (grip force, open-field tests), followed by more-
demanding ones (Morris water maze). Experimenters followed ARRIVE
guidelines: mouse groups were randomized, they were blind to the
genotypes, and software-based analysis was used to score mouse
performance in most of the tasks. All experiments were performed
between 09.00 and 16.00 h.
Immunofluorescence staining
Mice were perfused and the brains fixed for 72 h with 4% paraformaldehyde
in PBS and cryopreserved in 30% sucrose/PBS. Brains were flash frozen in
Cryomatrix (Thermo Fisher Scientific) and sectioned as described
previously (Ritchie et al., 2014). For immunostaining, antigen retrieval
was performed by incubating slides in 10 mM sodium citrate at 95°C for
10 min. Cooled slides were washed and incubated overnight in anti-ATRX
rabbit polyclonal antibody (Santa Cruz Biotechnology, SC-15408; 1:200,
H-300) (Watson et al., 2013) diluted in 0.3% Triton-X100 in PBS. Sections
were washed and incubated with goat anti-rabbit Alexa Fluor 594 (Life
Technologies) for 1 h. Sections were counterstained with DAPI and
mounted with SlowFade Gold (Invitrogen). Cell counts were done in three
control–KO littermate-matched pairs in a blinded manner.
Microscopy
All images were captured using an inverted microscope (DMI 6000b; Leica)
with a digital camera (ORCA-ER; Hamamatsu). Openlab image software
was used for manual image capture, and images were processed using the
Volocity software (PerkinElmer).
Haematoxylin and Eosin staining
Brain cryosections (8 μm thick) from 3-month-old mice were rehydrated in
70% ethanol for 2 min followed by tap water for 5 min. They were then
placed in CAT Haematoxylin (Biocare) for 2 min, placed under running tap
water for 1 min, and set in filtered Tasha’s Bluing Solution (Biocare) for
30 s. The slides were placed under running tap water for 10 min and set in
filtered Eosin Y (Fisher Scientific) for 2 min. Immediately afterwards, the
cells were dehydrated in 70% ethanol for 30 s each, then 90% ethanol for
1 min and 100% ethanol for 2 min each. The slides were placed in xylene 3×
for 5 min and mounted with Permount (Fisher Scientific) immediately after.
RT-qPCR
Total RNA was isolated from control and Atrx-cHet rostral cortex and
hippocampus using the RNeasy Mini Kit (Qiagen) and reverse transcribed
to cDNA using 1 μg RNA and SuperScript II Reverse Transcriptase
(Invitrogen). cDNA was amplified in duplicate using primers in the
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following conditions: 95°C for 10 s, 55°C for 20 s and 72°C for 30 s for 35
cycles. Primers detected Atrx exons 17 and 18. Standard curves were
generated for each primer pair. Primer efficiency (E) was calculated as E=
(10−1/slope−1)×100%, where a desirable slope is −3.32 and R2>0.990. All
data were corrected against β-actin.
ELISAs
Blood was collected from the inferior vena cava of P17 mice. One hundred
microlitres of 0.5 M EDTA pH 7.0 per millilitre of blood collected was
added to the blood sample and centrifuged at 21,000 g for 10 min at 4°C.
Plasma supernatant was collected and kept frozen at −80°C. Plasma IGF-1
concentration was measured using a mouse IGF-1 ELISA kit (R&D
Systems, MG100). Plasma GH (Millipore, EZRMGH-45K) and T4
(Calbiotech, T4044T) were also measured by ELISA according to the
manufacturers’ instructions.
Bone staining and measurements
Skinned and eviscerated P17 mouse carcasses were fixed overnight in 95%
ethanol and transferred to acetone overnight (Ulici et al., 2009). Fixed
skeletons were stained in a 0.05% Alizarin Red, 0.015% Alcian Blue, 5%
acetic acid in 70% ethanol solution for 7-14 days. Stained skeletons were
cleaned in decreasing concentrations of potassium hydroxide (2, 1 and 0.5%)
for several days and stored in 50:50 70% ethanol/glycerol solution. Alcian
Blue andAlizarin Red-stained skeletons were imaged using anOlympus SP-
57OUZ digital camera. The lengths of the tibia, femur and humerus, the
width of the skull and the length of the foot from at least four different
littermate pairs from both mouse models were imaged using the Zeiss Stereo
ZoomMicroscope Stemi SV6 andmeasured with a ruler accurate to 0.1 mm.
Hindlimb clasping, grip force, Rotarod, treadmill and open-field
tests
Hindlimb clasping was measured by lifting mice up by the base of the tail.
Clasping was scored on a scale of 0 (no clasping, limbs splayed) to 2
(clasping, wringing paws).
Grip force, an indicator of muscular strength, was measured using a Grip
Strength Meter (Columbus Instruments) (Solomon et al., 2013). The meter
was positioned horizontally, and the mice were held by the base of the tail
and lowered towards the triangular pull bar. Once the mice had gripped the
bar, the meter was calibrated, and the mice were gently pulled away from the
apparatus. The force applied to the bar as the mice released it was recorded as
peak tension (in newtons). This test was repeated five times, with the highest
and lowest value being removed for user error, and the remaining three
values were averaged for the final grip strength.
For the Rotarod task, mice were placed on the Rotarod apparatus (San
Diego Instruments) and rotation was increased from 5 to 35 rpm over 5 min.
Latency to fall was recorded automatically. Ten trials were performed on the
first day and four were performed on the second day. There was an inter-trial
period of 10 min, during which the mice were placed in their home cage.
Training for the treadmill test occurred over 4 days (3 min day−1). On the
first day, the incline was set to 5° and increased by 5° every day to a
maximum of 20°. The initial speed was 8 m min−1, and the treadmill was
accelerated by 1 m min−2. On the subsequent training days 2, 3 and 4, the
initial speed was increased to 10, 11 and 12 m min−1, respectively, with
constant acceleration. During testing on the fifth day, the initial speed was
12 m min−1 and accelerated to 20 m min−1 over the course of 15 min.
Distance to exhaustion was measured, and thework performed (W, in joules)
was calculated using the formula: W (J)=body weight (kg)×cos20°×9.8
(J kg−1×m)×distance (m).
In the open-field test, locomotor activity was automatically recorded
(AccuScan Instrument). The mice were placed in an arena with an area of
20 cm×20 cmwith 30-cm-high walls. Micewere acclimated to the locomotor
room for 10 min before testing. Locomotor activity was measured in 5 min
intervals over 2 h, as previously described (Martyn et al., 2012).
Elevated plus maze, Y-maze, fear conditioning and novel object
recognition
Animals were placed in the centre of the elevated plus maze (MedAssociate)
and their activity was recorded over 5 min. The total time spent in the
open and closed arms was recorded using computer software (AnyMaze).
The centre of the mouse body was used as an indicator of which zone they
were in.
Spontaneous Y-maze alternation was measured using a symmetrical
three-armed Y-maze as described (de Castro et al., 2009). Video tracking
was performed using computer software (AnyMaze) and the order and
number of entries into each arm recorded. Each mouse underwent one trial
lasting 5 min. Spontaneous alternation was counted when a mouse entered
all three arms in a row without visiting a previous arm.
To measure contextual fear, mice were placed in a 20 cm×10 cm clear
acrylic enclosure with a metal grid floor and onewall distinct from the others
(stripes were drawn on one of the walls). The chamber was equipped with an
electric shock generator. Videos were recorded using the AnyMaze video
tracking software. On Day 1, mice were allowed to explore the enclosure
freely, and at 150 s the mice were given a shock (2 mA, 180 V, 2 s). Shock
sensitivity was confirmed by vocalization of the mice. Thirty seconds later
the mice were returned to their home cage. After 24 h, the mice were placed
back into the enclosure for 6 min and freezing time was measured in 30 s
intervals. Freezing was defined as immobility lasting >0.5 s.
To test novel object recognition, mice were habituated with no objects in
an open arena (40 cm×40 cm) for 5 min on both Day 1 and Day 2. OnDay 3,
mice were placed in the arena with two identical objects (A; a red plastic ball
attached on top of a yellow cube base) and allowed to explore for 10 min.
Video tracking was used (AnyMaze). To test short-term memory, 1.5 h after
training the mice were placed back in the arena for 5 min with one previous
object (A) and one novel object (B; a blue plastic pyramid attached on top of
a green prism base). To test long-term memory, 24 h after training the mice
were placed back in the arena for 5 min with one previous object (A) and one
novel object (B). Recognition of previous and novel objects was expressed
as the percentage of time spent with each object compared with the total time
interacting. Interaction with the object was defined as sniffing or touching
the object, but not leaning against or standing on the object.
Morris water maze
The Morris water-maze test was conducted as described previously (Vorhees
and Williams, 2006). Mice were given four trials (90 s) a day for 4 days
consecutively, with a 15 min inter-trial period. The latency to find the
platform was recorded using video-tracking software (AnyMaze). If the mice
did not find the platform during the 90 s, they were gently guided onto the
platform. On the 5th and the 12th day, the platform was removed and time
spent in each quadrant of themaze recorded using the video software. The task
was performed in a pool 1.5 m in diameter with 25°C water, and the platform
was submerged 1 cmbeneath thewater surface. Spatial cues (shapes printed in
black and white) were distributed around the pool. For the cued version of the
Morris water maze, micewere subjected to four trials (90 s) per day for 7 days
consecutively, with a 30 s inter-trial period. If the mouse did not find the
platform after 90 s, it was gently guided onto the platform. The visible
platform and themouse starting location changed with each trial, so they were
unique between trials. The platform was made visible by placing a red plastic
cube on top of the platform, whichwaswiped with ethanol between each trial.
Statistical analyses
All data were analysed using GraphPad Prism software or SPSS, with
Student’s t-test (unpaired, two tailed) or one- or two-way ANOVA with
Bonferroni or Benjamini–Hochburg correction where indicated. All results
are depicted as means±s.e.m. unless indicated otherwise. Values of P≤0.05
were considered to indicate significance.
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Bérubé, N. G., Smeenk, C. A. and Picketts, D. J. (2000). Cell cycle-dependent
phosphorylation of the ATRX protein correlates with changes in nuclear matrix and
chromatin association. Hum. Mol. Genet. 9, 539-547.
Bérubé, N. G., Mangelsdorf, M., Jagla, M., Vanderluit, J., Garrick, D., Gibbons,
R. J., Higgs, D. R., Slack, R. S. and Picketts, D. J. (2005). The chromatin-
remodeling protein ATRX is critical for neuronal survival during corticogenesis.
J. Clin. Invest. 115, 258-267.
Bevins, R. A. and Besheer, J. (2006). Object recognition in rats and mice: a one-
trial non-matching-to-sample learning task to study ‘recognition memory’. Nat.
Protoc. 1, 1306-1311.
Cardoso, C., Timsit, S., Villard, L., Khrestchatisky, M., Fontes̀, M. and Colleaux,
L. (1998). Specific interaction between the XNP/ATR-X gene product and the SET
domain of the human EZH2 protein. Hum. Mol. Genet. 7, 679-684.
de Castro, B. M., Pereira, G. S., Magalhaẽs, V., Rossato, J. I., De Jaeger, X.,
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